Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study

BACKGROUND. The efficacy of ventriculolumbar perfusion (VLP) chemotherapy with methotrexate (MTX) was evaluated for treatment of leptomeningeal carcinomatosis (LMC). METHODS. The primary outcome was the response rate of increased intracranial pressure (ICP), which was available for comparison from h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gwak, Ho-Shin, Joo, Jungnam, Shin, Sang-Hoon, Yoo, Heon, Han, Ji-Youn, Kim, Heung Tae, Yun, Tak, Ro, Jungsil, Lee, Jin Soo, Lee, Seung Hoon
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2014
Materias:
Clinical Trial Results
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200999/
https://ncbi.nlm.nih.gov/pubmed/25209375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0199
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares